Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersDermatology Physician in Baton Rouge, LA
NPI: 1063603397Primary Employer
Lsuhn Billing LLC
lsuhsc.edu
HQ Phone
Get M.D. Jordan's Phone Numberphone_androidMobile
Get M.D. Jordan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardLA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 507 | 796 |
| 2 | 17000Destruction of skin growth | 290 | 473 |
| 3 | 17110Destruction of up to 14 skin growths | 266 | 366 |
| 4 | 17003Destruction of 2-14 skin growths | 223 | 1,325 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 216 | 306 |
Authors: Jing Jing Feng, Adam Brosz, Avika Dixit, Jacqueline Miller
Journal: Expert Rev Vaccines
Publication Date: 2024-09-09
Authors: Kai Wu, Jing Jing Feng, Adam Brosz, Jacqueline Miller, Lindsey Baden
Journal: J Infect Dis
Authors: Shishir Khetan, Stephen Walsh, Jing Jing Feng, Adam Brosz, Jacqueline Miller, Lindsey Baden, Frank Eder
Journal: Nat Med
Publication Date: 2023-08-31
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Placebo - SC, DRUG: Placebo - IV, DRUG: LY3509754, DRUG: LY3462817 - IV, DRUG: LY3462817 - SC
Lead Sponsor: Novavax
Collaborators: Department of Health and Human Services
Intervention / Treatment: BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Second Booster Vaccination), OTHER: Placebo (Crossover Vaccination period), BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), OTHER: Placebo (Initial Vaccination Period), BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period), BIOLOGICAL: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Booster Vaccination)